BARBARA GLEESON: Open Payments
NPI 1922087311 · PENNSAUKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 10 payments from 6 companies in 2025. Trend: 2023 $1,450 · 2024 $1,973 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $279 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, Wegovy, GARDASIL 9, Veozah, MOUNJARO, VERQUVO, ZORYVE, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
